Barclays
IBDQ

Barclays’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Barclays’s Portfolio IBDQ Stock Details IBDQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,975
Closed -$453K – 5423
2025
Q3 		$453K Hold
17,975
– – ﹤0.01% 3869
2025
Q2 		$453K Hold
17,975
– – ﹤0.01% 3809
2025
Q1 		$452K Hold
17,975
– – ﹤0.01% 3594
2024
Q4 		$450K Hold
17,975
– – ﹤0.01% 3887
2024
Q3 		$451K Hold
17,975
– – ﹤0.01% 3846
2024
Q2 		$447K Hold
17,975
– – ﹤0.01% 3101
2024
Q1 		$446K Hold
17,975
– – ﹤0.01% 3665
2023
Q4 		$445K Buy
+17,975
New +$440K ﹤0.01% 3954

Other funds holding IBDQ

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
BL
Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Barclays's IBDQ Position: Q4 2025 in Review

Barclays sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 17,975 shares — an estimated $453K sold.

Barclays first reported a position in IBDQ in Q4 2023 and held it in 8 quarters. The position peaked at $453K in Q3 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Barclays reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Barclays sold 17,975 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $453K.
  • Barclays first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q4 2023 and held it in 8 quarters.
  • Barclays's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $453K in Q3 2025.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.